|
|
||||||||
Ann Thorac Surg 2006;81:849-856
© 2006 The Society of Thoracic Surgeons
The Methodist DeBakey Heart Center, Houston, Texas
Accepted for publication August 29, 2005.
* Address correspondence to Dr Lawrie, 6560 Fannin, 1842, Houston, TX 77030 (Email: gmlawrie{at}att.net).
Presented at the Forty-first Annual Meeting of The Society of Thoracic Surgeons, Tampa, FL, Jan 2426, 2005.
| Abstract |
|---|
|
|
|---|
METHODS: Between February 1983 and June 2004, 607 mitral valve repairs were performed on one service. Of these, 410 patients had leaflet repair procedures: 152 were anterior leaflet repairs; isolated in 94, and combined with posterior repair in 58 patients. The results in these patients were compared with the results of posterior leaflet repair in 258 patients. All patients received flexible ring annuloplasty.
RESULTS: Age and sex of the anterior leaflet and posterior leaflet patients were similar: mean age 62.5 ± 14.3, 62.9 ± 14.9 years; males, 50.6%, p = not significant (NS). Preoperative ejection fraction was for anterior repairs 52.6 ± 12.8%; posterior repair, 58.2 ± 11.8%, p = NS. Coronary artery bypass was more frequently performed with anterior leaflet repair in 18 patients (19.1%) versus 45 (6.6%) for posterior leaflet repair (p = NS). The median number of chordae was similar in the anterior leaflet and posterior leaflet patients 4 (28), 4 (26), p = NS. Perioperative mortality was similar: anterior leaflet patients, 3.3% (2/94); posterior leaflet patients, 1.1% (2/258), p = NS. Hospital stay was for anterior leaflet patients and posterior leaflet patients: 12.86 ± 13.3 vs 11.0 ± 12.3, p = NS. Kaplan-Meier estimates of freedom from reoperation at 3 years were: for anterior leaflet patients, 91.9%: for posterior leaflet patients, 90.7%, p = 0.77. No structural polytetrafluoroethylene (PTFE) chordal failures were observed. Late echocardiographic data were obtained in 136 patients on 222 occasions at a mean of 3.2 ± 3.34 years. Severe mitral regurgitation was present in 10 patients (7.3%).
CONCLUSIONS: Repair of the anterior leaflet is facilitated by the use of PTFE replacement. Anterior leaflet repair can be performed reproducibly with the same results as posterior leaflet repair.
| Introduction |
|---|
|
|
|---|
| Material and Methods |
|---|
|
|
|---|
|
|
The MUMPS routines were used primarily for data record selection to find all patients who had primary mitral valve repair and to perform preliminary analyses. Formal statistical analyses were carried out in BMDP:
2 analyses for categorical data, analysis of variance for continuous variables, and Cox proportional hazard analysis for predictors of survival and freedom from reoperation. Both forward and backward stepping models were used. The S-Plus was used for Kaplan-Meier survival analyses and to plot the resulting graphs. Significant statistical differences were considered to exist if p was less than 0.05. There was no adjustment for multiple tests.
Surgical Techniques
Preoperative and intraoperative transesophageal echocardiographic images are reviewed. A standardized technique has been developed which is used for all prolapsing valve disease. The chest is entered either through a full median sternotomy or a limited lower sternal incision. The superior and inferior vena cavae are extensively mobilized. Cardiopulmonary bypass is established with bicaval 24-French cannulas, vena caval tapes, and dynamic venous drainage. The heart is arrested with retrograde cardioplegia. The left atrium is entered through an interatrial incision and the mitral valve is exposed. Stay stitches of 2-0 polypropylene are placed at the following: two at the commissures into the right and left fibrous trigones, and two or three in the posterior annulus. The annulus, valve leaflets, chordae, and papillary muscles are examined. The left ventricle is inflated with 75 to 100 mL of saline. The abnormal structures are identified. Leaflet prolapse is corrected by insertion of No. 5 PTFE sutures. The sutures are first placed into the bases of the posteromedial and/or anterolateral papillary muscles in a figure of eight fashion (Fig 1A).
|
The PTFE is tied down with ten throws and the knot is locked with a 6-0 polypropylene stitch tied over the end of the PTFE knot in order to prevent sliding of the PTFE knots. The annuloplasty ring is secured to the annulus with the previously placed commissural 2-0 sutures in continuous fashion (Fig 1F). The valve is again tested by saline insufflation of the left ventricle. The marking dots and PTFE knots should be buried in the line of apposition. The left atrium is closed. The air is evacuated, warm blood cardioplegia given, and the aorta unclamped. The operation is completed and the repair is checked by transesophageal echocardiography. Further technical details, including a video of this technique, are available at www.geraldlawriemd.com.
All patients underwent postoperative transthoracic echocardiography prior to discharge. Late echocardiographic data were obtained in 136 patients on 222 occasions at a means interval of 3.2 ± 3.3 years. There were 34 anterior leaflet patients, 28 bileaflet patients, and 74 posterior leaflet patients.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Comment |
|---|
|
|
|---|
After many years of unsuccessful experimentation with other chordal substitutes [19, 20] the decade of the 1980s saw PTFE suture introduced into clinical practice by Reveulta in Spain, Frater in New York, and David in Toronto [12, 13, 2123]. Chordal replacement with No. 5 PTFE suture has proven to be a simple, versatile, and durable technique in our own experience. It has a number of advantages. Normal chordae and normal leaflet motion are not disturbed as there is no need for native chordal transposition. The number of abnormal chordae which can be replaced is unlimited. This is particularly advantageous when both the anterior and posterior leaflets have severe prolapse. Indeed, the presence of severe bileaflet disease poses no difficulty. On the other hand, with older techniques severe bileaflet disease may be more difficult to repair and may be associated with mitral valve replacement in as many as 20% of patients when conventional chordal transposition procedures are attempted.
After our initial experience in a few cases with resectional techniques, all prolapsing anterior leaflets subsequently have been repaired with PTFE chordal replacement as the primary technique for more than 20 years. Perhaps the single greatest advantage of PTFE repair is the simplicity with which complete replacement of all chordae, if necessary, can be achieved. Indeed, the data in Table 3 clearly demonstrated that some anterior leaflets required such extensive chordal replacement that chordal transposition techniques would have been very difficult to apply.
The surgical technique described here is the systematic approach we use for every case of mitral valve leaflet prolapse regardless of site. The most important difference in the technique described compared with previous reports is that we have developed a method for realigning the edges of prolapsing segments with the PTFE chordae, which restores the original area of apposition of the leaflets. This method duplicates the end-diastolic state of the size of the chordae and the papillary annular distances. It allows the annular and chordal dimension to be adjusted together. This involves marking the line of apposition on the leaflets and then displacing the posterior annulus forward during inflation of the ventricle with saline in order to determine the size of permanent ring annuloplasty necessary to achieve physiological leaflet apposition and the final length of the PTFE chordae. This inflation simulates the end-diastolic elongation of the long axis of the left ventricle. This result is important not only to obtain resolution of the mitral regurgitation but also is critically important in reducing the stress on the new PTFE marginal chordae through the "keystone" effect [10, 11].
Stroke was uncommon after valve repair and the rates were similar for all the groups studied. We have not employed anticoagulation at any stage after surgery in patients with sinus rhythm and have had a very low incidence of thromboembolism. Sodium warfarin is prescribed only when chronic atrial fibrillation was present, left atrial thrombus was encountered, or preoperative thromboembolism had occurred. We studied the use of coumadin after mitral valve repair in a series of 561 isolated mitral valve repairs. We documented that, of 351 patients discharged in sinus rhythm on no coumadin, there were no strokes in the first six months after surgery [23].
The patients in this study with anterior leaflet prolapse had a higher incidence of previous myocardial infarction and more depression of left ventricular ejection fraction (Table 1). Despite this, their clinical outcome after PTFE repair was similar to the patients with only posterior lesions in regard to reoperation, echocardiographic results, and survival. A notable finding in this study was the deleterious impact of unbypassed coronary artery disease on overall survival and the beneficial effect of CAB on avoidance of reoperation.
The results of the analyses in this study comparing the results of PTFE chordal replacement with traditional resectional techniques demonstrated no differences in outcome despite the application of PTFE chordal repair to patients usually considered to be unrepairable by other techniques. Long-term echocardiographic follow-up for the Carpentier techniques is limited. The largest study is that of Flameng and colleagues (8) who studied 242 patients who had serial echocardiograms every 6 months. At 8 years after repair they documented 90.9 ± 3.2% patient survival and freedom from reoperation of 94.2 ± 2.3%. Freedom from grade 3/4 or 4/4 mitral regurgitation on echocardiography was 71.1 ± 7.4% at 7 years.
The clinical and echocardiographic results described here are similar to those documented in earlier reports of PTFE usage [15, 17, 24]. David and colleagues [15] documented no adverse impact of PTFE chordal reconstruction on any endpoint. The results of anterior leaflet repair in our experience were markedly better than that reported by Molitz and colleagues [25]. They experienced an 11% reoperation rate at 5 years and an 18% reoperation rate at 10 years. In the Cleveland Clinic experience [4, 5] in which the traditional Carpentier techniques were used, anterior leaflet repair was associated with a significantly higher risk of need for reoperation. Freedom from reoperation was 74% at 5 years for chordal shortening and 96% after chordal transfer.
We feel that our experience confirms the experience of others (6, 1218), that PTFE chordal replacement is a simple, expeditious, and durable technique for repair of mitral insufficiency arising from anterior leaflet prolapse. Given the fact that anterior leaflet repair has been widely reported to be a predictor of increased risk of need for reoperation, we find the fact that the anterior leaflet outcomes were similar to the posterior leaflet outcomes to be an encouraging finding of the study.
| Discussion |
|---|
|
|
|---|
In the anterior leaflet repair group, did you account for posterior leaflet height as this often affects the zone of coaptation length, and if so, how many of those patients had a sliding annuloplasty to augment the zone of coaptation? Furthermore, in your chordal replacement groups without a posterior slide, how many had systolic anterior motion of the mitral leaflet?
The second question relates to your illustration of a mixed bag of mitral regurgitation etiologies in your series. Some of these are ischemic. Of the 10% three-year failure rate in the posterior repair only, how many of those were true ischemic etiology as opposed to myxomatous or degenerative, and have you since altered your technique and approach by using a remodeling annuloplasty? Thank you.
DR LAWRIE: Well, as you saw, the ischemic group was in the minority. These were people who actually had ischemic damage that resulted in abnormal leaflet motion of the anterior leaflet, and so these people were treated with annuloplasty and reconstruction of the relevant area needed to stabilize the anterior leaflet. You will see occasional patients with anterior leaflet abnormalities from ischemia.
This technique is a nonresectional technique. I invite you to join our new society, PETL, People for the Ethical Treatment of Leaflets. We have completely given up, abandoned, never do resection of the anterior or posterior leaflet. I would humbly submit to you, and I know this is going to provoke perhaps more discussion, that there is no such thing as leaflet height and that there is no such thing as excessively large leaflets. Myxomatous degeneration is characterized by annuli that are double normal size, by leaflets that are double normal size, and by chordae that are double normal length. The mitral regurgitation occurs because of the diseased chordae.
The logical rational way to get the prolapsing leaflets replaced where they belong in my opinion is what I have shown you in this video. It is a marked overlap. We calculate the overlap, we mark it on the leaflet, and then we adjust the anatomy to do it. When you do this, you do not get systolic anterior motion. The average ring size in this group of patients is 31 to 33 mm. It is extremely rare at the end of the annuloplasty simulation maneuver to need more than a 31 mm annuloplasty.
Chordal replacement is not associated with SAM (systolic anterior motion), except perhaps in rare cases we have seen some chordal SAM, because we are using large annuloplasty rings, and the reason we are able to use large annuloplasty rings is we have not resected any of our leaflet area.
DR DANIEL H. DRAKE (Traverse City, MI): I also congratulate you on your presentation. It was excellent. Papillary muscle shortening as originally described by Professor Alain Carpentier is the technique that I prefer to use for the repair of anterior leaflet prolapse. Please explain your preference for artificial chords.
DR LAWRIE: We try to keep things as simple as possible, and artificial chordal replacement is an incredibly simple way of solving the problem. The pathology of myxomatous degeneration is that the chordae themselves have mechanical disability. This is what we saw from the data from the Cleveland Clinic studies that were published in the Journal of Thoracic and Cardiovascular Surgery. The mitral insufficiency of myxomatous disease is primarily a disease of the chordae, and we suggest that the rational treatment for that is chordal replacement, placing the chordae as I have shown and using the maneuvers I have shown that make it very easy to get the length correct.
DR KEVIN D. ACCOLA (Orlando, FL): Dr Lawrie, that's a very innovative thought process in regards to dealing with elongated chordae. From a technical perspective I would like to ask your sizing technique for the annulus. As you know, all these patients typically have annular dilatation with an increased anterior-posterior dimension. How do you account for this when you size the annulus since you are not using the typical annular sizing techniques we have all become accustomed to; that is, sizing the anterior leaflet or the intertrigonal space?
DR LAWRIE: That is a very good question, Kevin. The average annular size preop is in the 48 to 50 mm range. The fact of the matter is if you put a flexible ring annuloplasty on it, a symmetrically reducing annuloplasty around the posterior two-thirds of the annulus, you will reduce the size to 33 mm if you put a 33 mm ring.
Now, as far as the shape of the annulus is concerned, since we have been doing a lot of 3D echo in your unit, the fact is that the shape of the heart without any disciplinary measures is a D-shaped annulus. So we see something that is exactly what you are used to seeing except that is the natural shape of that annulus after it has been reduced and the leaflets are back in position.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. M. Lawrie, E. A. Earle, and N. R. Earle Nonresectional repair of the barlow mitral valve: importance of dynamic annular evaluation. Ann. Thorac. Surg., October 1, 2009; 88(4): 1191 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Maisano, I. Michev, S. Rowe, A. Addis, M. Campagnol, A. Guidotti, A. Colombo, and O. Alfieri Transapical endovascular implantation of neochordae using a suction and suture device Eur. J. Cardiothorac. Surg., July 1, 2009; 36(1): 118 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masuyama, A. Marui, T. Shimamoto, and M. Komeda Reversed L-shaped deformity of the anterior mitral leaflet and its reparative technique. J. Thorac. Cardiovasc. Surg., December 1, 2008; 136(6): 1599 - 1601. [Full Text] [PDF] |
||||
![]() |
P. Perier, W. Hohenberger, F. Lakew, G. Batz, P. Urbanski, M. Zacher, and A. Diegeler Toward a New Paradigm for the Reconstruction of Posterior Leaflet Prolapse: Midterm Results of the "Respect Rather Than Resect" Approach Ann. Thorac. Surg., September 1, 2008; 86(3): 718 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuntze, M. A. Borger, V. Falk, J. Seeburger, E. Girdauskas, N. Doll, T. Walther, and F. W. Mohr Early and mid-term results of mitral valve repair using premeasured Gore-Tex loops ('loop technique') Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 566 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Lawrie Ensuring proper leaflet apposition during mitral valve repair J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 228 - 228. [Full Text] [PDF] |
||||
![]() |
F. Y. Chen and L. H. Cohn Mitral Valve Repair Card. Surg. Adult, January 1, 2008; 3(2008): 1013 - 1030. [Full Text] |
||||
![]() |
A. M. Gillinov and M. K. Banbury Pre-Measured Artificial Chordae for Mitral Valve Repair Ann. Thorac. Surg., December 1, 2007; 84(6): 2127 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Gazoni, L. M. Fedoruk, J. A. Kern, J. M. Dent, T. B. Reece, C. G. Tribble, P. W. Smith, T. C. Lisle, and I. L. Kron A Simplified Approach to Degenerative Disease: Triangular Resections of the Mitral Valve Ann. Thorac. Surg., May 1, 2007; 83(5): 1658 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Suri, H. V. Schaff, J. A. Dearani, T. M. Sundt III, R. C. Daly, C. J. Mullany, M. Enriquez-Sarano, and T. A. Orszulak Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired? J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1390 - 1397. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |